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Aging is a complex biological process. Main factors that interplay in the aging process include free 
radicals and oxidation, insulin and insulin growth factors, sirtuins, mTOR, microbiome, lack of 
micronutrients, and declining proteasome activity which lead to cellular damage. Damaged cells are 
being replaced by somatic stem cells which proliferate to generate new cells. For each cell replication 
the telomeres of the related stem cells become shorter and this is the basic factor that modulates aging. 
Telomere length shortens with age and leads to senescence. Shorter telomeres are associated with 
increased incidence of aging related diseases and shorter lifespan. The percentage of short telomeres 
and rate of telomere shortening predicts longevity in mammals. Measurement of single telomeres 
through Q-FISH is the only reliable method to evaluate single telomere length and percentage of 
short telomeres. Repeated measurements at a distance of 6 months or a year can reveal the rate of 
change of the short telomeres, and response of patients to treatments, lifestyle, diet, supplementation 
and exercise modifications. A natural product telomerase activator TA-65, an astragalus extract, 
has been found to lengthen telomere in humans. By experimenting with different combinations of 
cycloastragenol (astragalus extract active molecule) we’ve able to increase telomerase activation in 
relation to the control cells.
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Модулирование процесса старения в организме человека:  
последние достижения в области биомаркеров  
для диагностики и лечения
Д. Цукаласа,б, П. Фрагкиадакиа, 
Е. Сарандиа,б, А. Тсатсакиса
аУниверситет Крита 
Греция, GR-70013, Крит, Ираклион, Университетский кампус Воутес 
бКлиника здоровья для аутоиммунных и хронических заболеваний 
Греция, 10674, Афины, ул. Коумпари, 5
Старение – это сложный биологический процесс. Основные факторы, участвующие в процессе 
старения и приводящие к повреждению клеток, включают свободные радикалы, процессы 
окисления инсулина, инсулиноподобные факторы роста, сиртуины, mTOR, микробиом, 
отсутствие микроэлементов и снижение активности протеасом. Поврежденные клетки 
заменяются соматическими стволовыми клетками, которые размножаются, генерируя 
новые клетки. При каждой клеточной репликации теломеры родственных стволовых клеток 
становятся короче, и это основной фактор, который модулирует старение. Длина теломер 
сокращается с возрастом и приводит к старению. Более короткие теломеры ассоциируются 
с увеличением заболеваний, связанных со старением и сокращением продолжительности 
жизни. Данные о процентном содержании коротких теломер и скорости сокращения теломер 
позволяют предсказать продолжительность жизни млекопитающих. Измерение отдельных 
теломер с помощью Q-FISH является единственным надежным методом оценки длины 
теломеры и доли коротких теломер. Повторные измерения через 6 месяцев или год могут 
выявить скорость изменения длины коротких теломер и реакцию пациентов на лечение, 
изменение образа жизни, диеты, пищевых добавок и физической активности. Было обнаружено, 
что натуральный продукт – активатор теломеразы TA-65, экстракт астрагала, удлиняет 
теломеры людей. Экспериментируя с различными комбинациями циклоастрагенола (активная 
молекула экстракта астрагала), мы смогли достичь активации теломеразы по сравнению с 
контрольными клетками.
Ключевые слова: старение, теломера, длина теломеры, теломераза.
Introduction
Aging is a process characterized by 
progressive decline of organ functions, increased 
incidence of age-related diseases and mortality 
(Cui et al., 2012; Romano et al., 2010). Although 
diseases associated with aging are mistakenly 
referred as diseases of the elderly, they are 
markedly distinct. Age-related diseases include 
cardiovascular disease (CAD, stroke), cancer, 
arthritis, osteoporosis, cataracts, diabetes, 
type 2, hypertension, chronic obstructive 
pulmonary disease and dementia (WHO, 
2011). Epidemiological data show that they are 
responsible for 2/3 of the global death burden, 
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while they account for 90% of disease in the 
industrialized world. Roughly 150.000 people die 
every day and 100.000 of them die due to age-
associated causes, making aging the greatest risk 
factor for death and disease. Non-communicable 
diseases (NCD) are the most common health 
problem in older age and their incidence is 
closely related to wealth. Heart disease, stroke, 
and chronic lung disease are the biggest killers 
of older people worldwide, though in low-income 
countries older people carry a greater disease 
burden than those in the rich world (Prince et al., 
2015). Previous studies have described telomere 
length as promising emerging biomarker for use 
in colorectal cancer which is placed in the third 
place among the most diagnosed cancer in men 
(Nikolouzakis et al., 2018). Age-related diseases 
cause disability through sensory impairments, 
back and neck pain, chronic obstructive 
pulmonary disease, depression, falls, diabetes, 
Alzheimer disease, and osteoarthritis (Frasca 
et al., 2017). Previous studies have summarized 
the current state of knowledge on the role of 
telomeres in mental disorders with the most 
common being depression, schizophrenia and 
stress-anxiety. Most studies report reduced 
telomere length in patients suffering from mental 
disorders, compared to the general population. 
Since the factors that can affect telomere length 
are various, more experiments and investigations 
are required to understand the general impact of 
different factors on telomere length (Vakonaki et 
al., 2018).
The term aging refers to the increase of 
biological age and not the chronological. There 
is only a weak association between biological 
age with a person’s age in years. Indeed, some 
80-year-olds have physical and mental capacities 
similar to 20 years-old individuals. Also, health 
in older age is not random. Although some of the 
differences in older people’s health reflect their 
genetic inheritance, most are due to epigenetic 
factors, their physical and social environments. 
It’s important to note that epigenetic factors start 
to influence aging since childhood (Benayoun et 
al., 2015).
Aging is a multifactorial process
Several factors have been suggested to 
interplay in aging, including free radicals and 
oxidation, mitochondrial dysfunction, insulin 
and insulin growth factors, sirtuins, mTOR, 
microbiome, lack of micronutrients and declining 
proteasome activity (Fig. 1). The biological 
significance and their role in the process of aging 
will be further discussed.
Free radicals and oxidation have been long 
suggested to be the leading cause of aging, 
while another theory indicates mitochondrial 
dysfunction as the key player (Romano et al., 
2010). Oxidative stress reflects the imbalance 
between the production of reactive oxygen 
species (ROS) and the antioxidant defenses. The 
free radical theory stated that oxidative stress 
causes damage to cell components – proteins, 
lipids, and DNA through the release of excessive 
free radicals (Betteridge, 2000).
Mitochondrial dysfunction theory of aging 
is a modification of the free radical theory, 
and suggests that cumulative damage to the 
mitochondria and their DNA (mtDNA) caused by 
free radicals is the central factor of aging (Payne 
& Chinnery, 2015).
Insulin and insulin growth factor-I (IGF-I) 
reduced signaling predict increased longevity 
in organisms ranging from yeast to mammals 
(Parrella et al., 2015; Milman et al., 2014). 
Disruptions of the circadian rhythm, the natural 
feeding and the fasting cycle facilitates increased 
calorie intake and contribute to metabolic 
diseases that may accelerate the aging process. 
Alternating periods of feeding with periods 
of fasting, as in time restricted feeding, fast 
mimicking diets and periodic or intermittent 
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fasting, impart pleiotropic benefits have been 
associated with the down regulation of IGF-1 
and improvement of insulin sensitivity (Lee et 
al., 2014). Metformin protective effects against 
several age-related diseases in humans have been 
associated with decreased insulin resistance and 
IGF-1 signaling. Those effects will be tested in 
the TAME (Targeting Aging with Metformin) 
trial. Insulin and IGF-1 are also central regulating 
factors for the SIRT-1 (sirtuin) and mTOR 
pathways (Watroba & Szukiewicz, 2016; Barzilai 
et al., 2016).
Sirtuins are a class of nicotinamide adenine 
dinucleotide (NAD+)-dependent deacetylases, 
and have been suggested to be potent in prevention 
of aging and age-related diseases, and even 
reverse aspects of aging (Bonkowski & Sinclair, 
2016). Sirtuins contribute to cellular regulation 
of many metabolic functions related to aging, 
including DNA repair, autophagy, apoptosis, 
genome stability, and mitochondrial functions 
(Watroba & Szukiewicz, 2016).
The mTOR (mechanistic target of rapamycin) 
pathway directly influences protein synthesis, 
transcription, autophagy, metabolism, and 
organelle biogenesis and maintenance (Lipton & 
Sahin, 2014). Inhibition of the mTOR pathway 
has a protective effect against age-related diseases 
and extends lifespan in model organisms. 
Several mTORinhibitors have been approved 
for a variety of clinical uses, and others are 
under clinical development. Adverse side effects 
currently hinder the use in healthy individuals, 
though encouraging early data suggest that drugs 
targeting the mTOR pathway could be widely used 
to slow aging and reduce age-related pathologies 
in humans (Johnson et al., 2013).
The microbiome is a population of microbes 
that form a “meta-organism” comprising of 
ten bacterial cells for each human cell. The 
microbiome plays a critical role in modulating 
the rate of the phenotype of aging. Diffusible 
molecules released by the bacteria directly affect 
cells of the host, and recent studies indicate that 
these interspecies signaling impacts host aging 
rate (Heintz & Mair, 2014).
Lack of micronutrients accelerates aging 
through mitochondrial decay, DNA damage, such 
as chromosome breaks, and metabolic disruption. 
Most people are characterized by inadequate 
dietary intake of vitamins and minerals, most 
likely due to excessive consumption of high 
calorie, micronutrient-poor, processed food. Poor 
nutrition is linked to increased risk of many age-
related diseases, including cancer, heart disease, 
and diabetes (Ames, 2006).
Reduced ability to maintain a proteostasis 
and a functional proteome is one of the hallmarks 
Fig. 1. Factors affecting aging. The multifactorial process of aging is affected by free radicals and oxidation, 
mammalian target of rapamycin (mTOR), sirtuins, dysfunction of mitochondria, lack of micronutrients, insulin 
and insulin growth factor (IGF), decline of the proteasome activity and the microbiome
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of aging. Under normal conditions, degradation 
of damaged proteins occurs through efficient 
proteolysis by the ubiquitin-proteasome system. 
With age, damaged and misfolded proteins 
accumulate due to the inefficient function of the 
proteasome pathway and impair cell function and 
tissue homeostasis. The accumulation of damaged 
proteins occurs in multiple age-associated 
pathologies such as Alzheimer’s, Parkinson’s or 
Huntington’s disease (Vilchez et al., 2014).
The common denominator
All these mechanisms cause cellular damage, 
which eventually brings to autophagy and cell 
apoptosis. Damaged cells are replaced by tissue 
stem cells which divide every time to generate 
new tissue cells. Adult somatic stem cells reside 
in specific tissues within most of our organs, 
possess self-renewal capacity and can repair or 
replace cells and tissues damaged by injury or 
disease. These cells are stored in a protected 
environment niche, where they are connected 
to supporting cells, and kept dormant until an 
appropriate activating signal. Tissue-specific 
adult stem cells proliferate to replace senescent 
or deteriorated cells, maintaining the organ 
structure and function. They can repair mild 
injuries in various organs and tissues including 
the skin, liver, intestine, kidney, and bone marrow 
(Montagnani et al., 2016). Aging coincides with a 
decreased regenerative capacity of stem cells and 
shortening of telomeres.
Telomere length and aging
Telomeres’ functional role is to prevent gene 
loss from enzymatic nucleotide degradation and 
genome instability. Repetitive 5’-TTAGGG-3’ 
sequences of 70 to 100 nucleotides bound to 
telomeric interacting proteins provide a protective 
cap of the chromosomal DNA, resembling the 
end of a shoelace (Fig. 2). To exert DNA repair 
mechanisms, single-stranded telomeric DNA 
form T-loop structures at the tip of chromosomes 
(Griffith et al., 1999). Normal diploid cells lose 
telomeric DNA during DNA replication due to the 
end replication problem. Thus, somatic cells have 
a certain lifespan until they reach a critically short 
length which will result in one of the following 
cell fates: senescence, cell death by apoptosis, 
genomic instability due to the fusion of telomeres. 
Fused chromosomes break unequally in mitosis, 
leading to genomic instability and chromosomal 
rearrangements during cell divisions (Muraki et 
al., 2012; O’Sullivan & Karlseder, 2010). On the 
other hand, cells with high proliferation capacity 
(i.e., germ cells, adult stem cells) manage to avoid 
chromosome erosion by expressing telomerase, 
an RNA-dependent DNA polymerase which binds 
Fig. 2. Telomeres are protective caps of chromosomes (Tapis F.) (Adapted with permission by Shutterstock)
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to telomeric DNA using the RNA complementary 
sequence as a template, allowing the maintenance 
of telomere length. Telomere length is established 
by the outcome of two opposing forces: on one side 
telomere erosion generated during cell division 
by the end-replication problem, exonucleases, 
and oxidative activities; on the other side telomere 
elongation by telomerase and recombination-based 
processes known as alternative lengthening of 
telomeres or ALT. Greider C.W., Blackburn E.H., 
and Szostack J. were the first to identify the role 
of telomerase in chromosomal elongation in 
eukaryotic cells (Greider & Blackburn, 1987) 
and the protective role of telomeric DNA from 
nucleotide degradation (Greider & Blackburn, 
1985). These great discoveries were awarded 
The Nobel Prize in Physiology or Medicine 2009 
and shed new light on disease mechanisms and 
aging.
Telomeres: biological clock
Recent studies indicate that telomere 
length, which can be affected by various lifestyle 
factors, can affect the pace of aging and onset of 
age-associated diseases. Stem cell dysfunction 
provoked by telomere shortening may be one of 
the mechanisms responsible for organismal aging 
in both humans and mice. Cell replication rate, 
cumulative exposure to damaging agents, low 
activity of the telomerase enzyme are the cause 
of erosion of telomeres (Aviv, 2008). Agents 
that cause DNA damage (such as oxidative, 
inflammatory, endocrine and other forms of 
biological stress), ROS, mitochondrial damage, 
DNA damage, lack of micronutrients, misfolded 
proteins accumulation, faulty microbiome 
signaling, insulin resistance, IGF-1 up-regulation, 
mTOR and sirtuins dis-regulation, cause damage 
at a cellular and tissue level (DiLoreto & Murphy, 
2015). Accordingly, Funk et al. have found that 
telomerase expression restores dermal integrity 
to in vitro-aged fibroblasts in a reconstituted 
skin model (Funk et al., 2000) and recently it 
was demonstrated that telomere re-lengthening 
through telomerase activation could reverse aging 
phenotype in mice (Jaskelioff et al., 2011). It was 
the first time in history to invert aging process 
in mammals. Previous studies suggested that 
female human fertility decreases with increased 
maternal age and that various adverse factors, 
including alterations in telomerase activity, can 
contribute to age-associated infertility in women. 
The fact that telomerase activity is regulated 
in a time- and location-dependent manner in 
both embryo and placental tissues, highlights 
it potential importance to the successful 
completion of pregnancy. Since maternal age is 
a crucial determining factor for the success of in 
vitro and in vivo fertilization, numerous studies 
have focused on telomerase activity and its 
correlation with mammalian fertilization, as well 
as the following cleavage and pre-implantation 
developmental processes. Associations between 
telomerase activity and pregnancy complications 
have been previously observed. Fragkiadaki et 
al. summarize and critically discuss evidence 
correlating telomerase activity with pregnancy 
complications (Fragkiadaki et al., 2016). Diverse 
lifestyle, environmental and nutritional factors 
influence positively or negatively telomere length. 
Some of the factors that negatively influence 
telomere length are smoking, alcohol, stress, 
vitamin D and C deficiency, obesity, oxidation 
and drugs (Shammas, 2011; Rode et al., 2015). 
On the other hand, nutrition, antioxidants, omega 
3, exercise and telomerase activators are some 
of the factors that positively influence telomere 
length (Ornish et al., 2013).
Telomere shortening is a biological clock 
that indicates the pace of aging (Fig. 3). Telomere 
length at birth can vary from 5000-15000 pair 
bases, so the rate of telomere shortening is a 
more robust biomarker than the absolute telomere 
length. At birth, the average telomere length 
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is 10.000 bps. At 20 years of age, the average 
telomere length is around 8.000 bps. Gradual loss 
of 35-150 base pairs per year leads to telomere 
length of 4500 bps where the chromosomes are 
unstable and the probabilities of serious health 
problems and death increase exponentially. A 
person that loses 35 bps instead of 150 bps per 
year, ages at a five times slower pace (Lansdorp 
et al., 1996; Okuda et al., 2002).
Rate of telomere shortening  
predicts longevity
The two main methods to assess telomere 
length are Polymerase chain reaction (PCR) and 
Quantitative Fluorescence in Situ Hybridization 
(Q-FISH). Various methods of TL measurement 
have been developed as reviewed by (Montpetit 
et al., 2015). Terminal Restriction Fragment 
(TRF) analysis which gives a crude analysis 
of MTL, and qPCR which estimates relative 
levels of MTL, have been widely used in large 
population studies. Even though these are low-
cost methods and require only minimum amount 
of biological sample, they present various 
limitations, including low sensitivity and lack 
of reproducibility. Importantly their inability to 
estimate the individual TL and detect critically 
short telomeres (<3kb) limits their application 
in diagnostics. Q-FISH provides the ability to 
quantify the telomere length in 92 individual 
telomeres, gives data on short telomeres 
percentage and can also be used as a clinical 
diagnostic tool (Fernández-Alvira et al., 2016; Vera 
& Blasco, 2012). Moreover, “telomere free” ends, 
chromosomes lacking telomere sequences large 
enough to be detected, require a highly sensitive 
methods to be identified. Q-FISH of telomeric 
parts in metaphase chromosomes employs high-
level methodology and equipment used by skilled 
cytogeneticists to assess the 184 telomeric ends 
in individual samples. This method provides 
results on median length of single telomeres, the 
Fig. 3. Telomeres shortening and cell division (Designua) (Adapted with permission by Shutterstock)
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percentage of short telomeres and percentage of 
critically short telomeres (<3kb), and gives an 
overview of the rate of telomere shortening and 
longevity (Vera et al., 2012; Ledford, 2007). It is 
known that the rate of increase of the percentage 
of short telomeres predicts longevity in mammals 
(Vera et al., 2012).
Toxplus, a spin-off company from 
University of Crete, and Metabolomic Medicine 
of Athens have developed a semi-automated 
worksheet with more than 100 participants, 
for providing telomere length statistics. In 
this database a big but not enormous dataset 
is made for a person, each person have at least 
1840 measures for an analysis (10 metaphases 
x 23 chromosomes x 2 chains x 4 telomeres 
tails), chronological age and medical history 
(e.g. drugs, alcohol consumption, exposure 
on pesticides) (Tsoukalas et al., 2018). Basic 
statistics and figures for each of the participant 
such as: percentage of critically short telomeres 
(<3000 kbases), chromosome length distribution 
and graphs of biological age vs chronological 
person’s age. The database consists of leucocyte 
telomere length measurements (LTL) of different 
age groups within a healthy adult population, 
through Q-FISH, creating a reference range 
based on age and percentile distribution of 
LTL. Repeated measurements at a distance of 
6 months or a year can reveal the rate of change 
of the short telomeres, and response of patients 
to treatments, lifestyle, diet, supplementation 
and exercise modifications.
Telomerase activators are substances and 
methods that can activate the expression of 
the enzyme telomerase. Telomerase activation 
has been achieved through natural molecules, 
synthetic molecules and genetic manipulation 
and intervention. A natural product telomerase 
activator marketed since 2008, TA-65 is an 
extract of the herb astragalus. This has been 
found to lengthen telomeres in humans. The 
active molecule in TA-65 is cycloastragenol. 
Cycloastragenol can be isolated from various 
species in the genus Astragalus. It has been 
suggested to have telomerase activation activity. 
An in vitro study on human CD4 and CD8 T 
cells suggest that cycloastragenol increases 
telomerase activity and reduce the effects of 
aging (Valenzuela et al., 2009). Product B has 
also been suggested to be a potent telomerase 
activator. It is a herb nutraceutical, contains 
“telomere support” compounds and antioxidants 
and it has been promoted by Bill Andrews one of 
the discoverers of human telomerase, but there is 
no long-term test data available. The first study 
of the effect of telomerase activation in humans 
by Harley et al. was for TA-65 which has been 
isolated from a proprietary extract of the dried 
root of Astragalus membranaceous (Harley 
et al., 2011). Studies on TA-65 in humans and 
animals support improvements in biomarkers 
of aging, including immune, cardiovascular, 
metabolic, bone (de Jesus et al., 2011). Toxplus 
company and Metabolomic Medicine of Athens 
measure telomerase activation in herbal extracts, 
searching for human telomerase activators. They 
test these in human normal peripheral blood 
mononuclear cells (PMBCs), using a commercial 
telomerase polymerase chain reaction–enzyme-
linked immune sorbent assay (Tsitsimpikou et 
al., 2013).
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